Breeze Meds review
Named pharmacies, starting prices only
Compounded semaglutide from $199 a month, tirzepatide from $399 and oral versions of both, from a Georgia telehealth service that names its four pharmacies and two lead physicians but publishes only starting prices.
Our verdict
Breeze Meds is open about the parts of the supply chain that often stay vague and closed about the part buyers compare first. Its FAQ names the clinician group, Lion MD, its two lead physicians with NPI numbers you can look up, and four compounding pharmacies with phone numbers. Its menu covers injectable and oral semaglutide and tirzepatide, plus NAD⁺ and sermorelin. Prices, though, are "starting at" figures only: semaglutide injection $199 a month, tirzepatide injection $399, oral semaglutide $299 and oral tirzepatide $399, with no dose ladder, plan terms or refill price behind them. Its own FAQ titled "What are the costs involved, and do you accept insurance?" answers with a delivery timeline. Expect two to three weeks from consultation to medication, and get the full price in writing before you pay.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Access
- Semaglutide from $199/mo, tirzepatide from $399; oral from $299; starting prices only
- Medications
- Semaglutide · Tirzepatide · Oral
- Insurance
- Cash-pay, no insurance
- Visit
- Async intake
- Availability
- All 50 states claimed; no list published
Partner alternative
Enhance MD
Lab-guided treatment under ongoing physician oversight
Check Enhance MD availability →What it is
A cash-pay telehealth service focused on weight loss, with a smaller wellness line. Weight loss: compounded semaglutide and tirzepatide, each as a weekly injection or a once-daily dissolvable tablet. Wellness: NAD⁺ as a weekly injection (a 20 mL bottle) or a nasal spray, and a sermorelin injection. The operating entity is described in its privacy policy as Breezemeds, LLC, "a Delaware corporation," at 134 South Avenue SE, Marietta, Georgia, while the site footer reads "Breezemeds, Inc." Clinical care runs through a nationwide group the site calls Lion MD, led by Dr. Ana Lisa Carr, MD (NPI 1689841744) and Dr. Kelly Tenbrink, MD (NPI 1346482684). Breeze does not compound anything itself; four outside pharmacies do.
How it works
The path is a short online questionnaire, a medical consultation with a licensed provider matched to your history, and discreet shipping with ongoing support. Breeze says the whole process typically takes two to three weeks from the first consultation to medication in hand, covering the consultation, prescription review and "expedited" delivery. That is slow for a GLP-1 service, but it is stated up front. The FAQ says all providers are board-certified and experienced in weight management and that the service covers all 50 states; no state exclusions are listed. Treatments are marketed as FSA and HSA eligible. The four named pharmacies are Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx, each listed with a phone number, which lets you call the pharmacy directly about a shipment or a formulation question. The FAQ does not say which of the four will fill a given order, so ask at intake if you care which one compounds your medication. The same clinician group and the same four pharmacies appear in near-identical language on Synergy Rx and CareBareRX, so choosing among those three does not change who prescribes or who fills.
Pricing transparency
Every published figure is a starting price. The weight-loss cards read: GLP-1 (semaglutide) injection starting at $199, tirzepatide injection starting at $399, oral semaglutide starting at $299 and oral tirzepatide starting at $399; the weight calculator lists the semaglutide injection as "Starting at $199/mo," the only place a billing period appears. The wellness cards read: NAD⁺ injection starting at $169, sermorelin injection starting at $100 and NAD⁺ nasal spray starting at $210, with no period stated. Nothing on the public site says what dose each starting price covers, whether the price rises as the dose rises, whether there are multi-month plans, what a refill costs, or how cancellation and refunds work, and the questionnaire asks your goals before it shows any plan. Insurance is never addressed, though the cost FAQ heading raises it. Treat the starting figures as the floor, not the price, and ask for the monthly cost at your expected maintenance dose, the refill price and the cancellation terms before you pay. Tirzepatide at a $399 starting price sits well above most compounded options.
Branded vs compounded
Compounded semaglutide and tirzepatide, injectable and oral, prepared by one of the four named partner pharmacies. Compounded preparations are not FDA-approved and are not therapeutically equivalent to Wegovy, Ozempic, Mounjaro or Zepbound, and oral compounded versions have far less supporting data than the injectables; the weight-loss trials behind both molecules used branded injections at full titration. The homepage's results claims, "lose 15–20% of their body weight" on average and "85% of patients lose 10%," are not tied to any cited study or to Breeze's own patient data. NAD⁺ injections and nasal sprays carry far less human-outcome evidence than the GLP-1s: the controlled trials sit with oral NR and NMN and show biomarker changes, not outcomes. Sermorelin has a real growth-hormone-axis mechanism and thin long-term outcome data.
Pros and watch-outs
What we like
- Names all four partner pharmacies — Belmar, Strive, Epiq Scripts and Casa Pharma Rx — each with a phone number a patient can call
- Names the clinician group and its two lead physicians with NPI numbers, so the credential is verifiable
- Injectable and oral versions of both semaglutide and tirzepatide
- Semaglutide injection starts at $199 a month
- States its own turnaround honestly at two to three weeks
- Names its operating entity and a street address in its privacy policy
- FSA and HSA eligible
Watch-outs
- Only starting prices are published; no dose ladder, plan terms or refill price
- Tirzepatide starts at $399 a month, injectable or oral
- The FAQ item about cost and insurance is answered with a delivery timeline; insurance is never addressed
- No published cancellation or refund terms
- Two to three weeks from consultation to medication
- Results claims ("15–20%" average loss, "85% of patients lose 10%") cite no study or data source
- One company, two corporate forms: "Breezemeds, LLC, a Delaware corporation" in the privacy policy and "Breezemeds, Inc." in the footer
- The clinician group and pharmacy roster are shared with CareBareRX and Synergy Rx
Best for
People who want to know which pharmacies may compound their medication and which physicians are accountable for the prescription, want an oral GLP-1 option, and will get the full price in writing before they pay.
Who should look elsewhere
Anyone comparing monthly costs across providers from published figures, anyone who needs to know whether insurance applies, or anyone who wants medication in days rather than weeks.
The evidence behind what Breeze Meds prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term, but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Sermorelin benefits: does it work? What the trials show
A real GHRH drug, read against the anti-aging pitch: an approved growth-hormone-releasing analog with a pediatric track record, and a longevity case built more on biomarkers than outcomes.
How Breeze Meds compares
A few alternatives worth a look, depending on what you’re optimizing for.
- HealthRX
Low-cost compounded GLP-1 with overnight shipping and physician review
See HealthRX → 
Strut HealthA general telehealth that covers GLP-1 alongside other everyday care
See Strut Health →
Synergy RxCompounded GLP-1 access with integrated pharmacy fulfillment
See Synergy Rx →
More GLP-1 telehealth reviews: HealthHubFifty 410Fitness RXFitstryFlorida Weight Loss MDFormBlends
Access & cost
How we assessed this. This review reflects Aminoscope’s own read of Breeze Meds’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does Breeze Meds disclose its pharmacy?
- Yes. Its FAQ names four partner pharmacies — Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx — each with a phone number. It also names the clinician group, Lion MD, and its two lead physicians with NPI numbers. It does not say which pharmacy fills a given order. The identical roster appears on Synergy Rx and CareBareRX, so choosing between those three does not change who fills the prescription.
- What does Breeze Meds cost per month?
- Only starting prices are published: compounded semaglutide injection from $199 a month, tirzepatide injection from $399, oral semaglutide from $299 and oral tirzepatide from $399. NAD⁺ injection starts at $169, NAD⁺ nasal spray at $210 and sermorelin at $100. The site does not say what dose each figure covers, whether it rises with dose or what a refill costs, so ask for the monthly price at your expected maintenance dose before you commit.
- Does Breeze Meds take insurance?
- The site never says. Insurance appears in the wording of one FAQ heading and nowhere in the answer beneath it, and no other page addresses it. Treat it as a cash-pay service and confirm at intake. Breeze does state that its treatments are FSA and HSA eligible.
- How long does Breeze Meds take?
- Its own FAQ says the process typically takes two to three weeks from initial consultation to medication in hand, covering the consultation, prescription review and delivery. That is slower than overnight-shipping services, and it is stated up front rather than discovered after payment.
- Is Breeze Meds legit?
- Breeze Meds is a GLP-1 telehealth service you reach through an online intake a clinician reviews. The medications it names are Semaglutide, Tirzepatide and an oral form. Its stated availability: All 50 states claimed; no list published. What it publishes up front: Semaglutide from $199/mo, tirzepatide from $399; oral from $299; starting prices only. It is cash-pay and states it does not bill insurance. Those are the provider's own published claims rather than checks we could run ourselves, so get the ones that matter to you confirmed in writing before you pay.
- Is Breeze Meds expensive compared with other GLP-1 telehealth providers?
- Breeze Meds publishes a starting figure of $179/mo. Across the 112 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $399 with a median of $179, which puts Breeze Meds right at the median. The other 173 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.